260
Views
5
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Pramipexole augmentation in treatment-resistant major depressive disorder

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ewa Kurczewska, Ewa Ferensztajn-Rochowiak, Filip Rybakowski, Michał Michalak & Janusz Rybakowski. (2021) Treatment-resistant depression: Neurobiological correlates and the effect of sleep deprivation with sleep phase advance for the augmentation of pharmacotherapy. The World Journal of Biological Psychiatry 22:1, pages 58-69.
Read now

Articles from other publishers (4)

F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva & F. Drago. (2018) International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets. Pharmacological Reviews 70:3, pages 475-504.
Crossref
Murugaiah A. M. Subbaiah. (2017) Triple Reuptake Inhibitors as Potential Therapeutics for Depression and Other Disorders: Design Paradigm and Developmental Challenges. Journal of Medicinal Chemistry 61:6, pages 2133-2165.
Crossref
Mark A. Oldham & Hochang B. Lee. 2017. Restless Legs Syndrome/Willis Ekbom Disease. Restless Legs Syndrome/Willis Ekbom Disease 21 43 .
Sidney H. KennedyRaymond W. LamRoger S. McIntyre, S. Valérie Tourjman, Venkat Bhat, Pierre Blier, Mehrul Hasnain, Fabrice Jollant, Anthony J. Levitt, Glenda M. MacQueen, Shane J. McInerney, Diane McIntosh, Roumen V. Milev, Daniel J. Müller, Sagar V. Parikh, Norma L. Pearson, Arun V. Ravindran & Rudolf Uher. (2016) Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder. The Canadian Journal of Psychiatry 61:9, pages 540-560.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.